Drug factory · FDA FEI 3011860409
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
No. 369 Yuzhou South Road, Lianyungang, China
Problems found, fixed voluntarily at FDA's last inspection, Jan 30, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2024: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Aprepitant | Makes it, tests it, packages it and labels it | Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Hepalink USA Inc. | 71731-5111, 81952-911 |
| Eribulin | Makes it, tests it, packages it and labels it | Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Sun Pharmaceutical Industries Limited | 71731-4171, 70095-080 |
| Fulvestrant | Makes it, tests it, packages it and labels it | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 71731-6121 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jan 30, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Apr 5, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack; sterilize.